Matt Buderer, R.Ph., FIACP, of Buderer Drug Company is a partner in The Manchester Group, LLC. Matt and this group of researchers recently developed a new cold remedy. This cold remedy earned US patent number 61/083,246. It is expected to debut on store shelves for the 2009 cold and flu season.

Pictured are Manchester Group members Andy McPherson, Gene Gresh, Paul Levesque, Dr. Jeff Leighton, George Roentsch and Rebecca Montrone. (Matt Buderer and Tom Marks not pictured)

The Manchester Group is currently collaborating on other projects with Maine Natural Health, founded by Jeff Leighton, MD, PhD. Dr. Leighton studied chemistry and natural product isolation, pharmacology and medicine at University of Virginia and went on to a career in pharmaceutical and biotechnology industry (Principle Scientist at Burroughs Welcome, V.P Research at Glaxo and CEO/CSO/Founder of many biotechnology companies) but has now turned his focus to all-natural approaches for the prevention and treatment of disease.

The Manchester Group is dedicated to the formulation and provision of cutting-edge health products based on botanicals and other natural ingredients. On this page you will find information about select products we are bringing to open trial. Keep checking back for new studies in which you may wish to participate! Subscribe to the mailing list on www.wondrousroots.com to receive notification of new studies.

Herpes Cold Sore Formula
If you suffer from outbreaks of herpes cold sores (HSV1) and are interested in being part of an open trial to test this product, please notify Matt Buderer, R.Ph. and when we are ready to launch the trial we will contact you with further information. Those who apply and are accepted will receive free product for the trial period and another supply upon return of the study data. Thank you!